Yu‐Feng Wei

2.0k total citations
52 papers, 669 citations indexed

About

Yu‐Feng Wei is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Infectious Diseases. According to data from OpenAlex, Yu‐Feng Wei has authored 52 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 10 papers in Infectious Diseases. Recurrent topics in Yu‐Feng Wei's work include Lung Cancer Treatments and Mutations (16 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers) and Asthma and respiratory diseases (8 papers). Yu‐Feng Wei is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers) and Asthma and respiratory diseases (8 papers). Yu‐Feng Wei collaborates with scholars based in Taiwan, United States and China. Yu‐Feng Wei's co-authors include Ping‐Hung Kuo, Ying‐Huang Tsai, Sung Sook Lee, Gee‐Chen Chang, Barbara Collins, James Chih‐Hsin Yang, Dong‐Wan Kim, Leora Horn, Gyeong‐Won Lee and Gianluca Laus and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Yu‐Feng Wei

48 papers receiving 659 citations

Peers

Yu‐Feng Wei
Athena Gogali Greece
Hideo Ichimura Japan
Chin‐Hao Chang Taiwan
Mehmet Sinan Dal Türkiye
Choonghyun Ahn South Korea
Nathan Rubin United States
Kristen T. Leeman United States
Colin Robertson Australia
Mohammad F. Madhoun United States
Ryo Suzuki Japan
Athena Gogali Greece
Yu‐Feng Wei
Citations per year, relative to Yu‐Feng Wei Yu‐Feng Wei (= 1×) peers Athena Gogali

Countries citing papers authored by Yu‐Feng Wei

Since Specialization
Citations

This map shows the geographic impact of Yu‐Feng Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Feng Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Feng Wei more than expected).

Fields of papers citing papers by Yu‐Feng Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Feng Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Feng Wei. The network helps show where Yu‐Feng Wei may publish in the future.

Co-authorship network of co-authors of Yu‐Feng Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Feng Wei. A scholar is included among the top collaborators of Yu‐Feng Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Feng Wei. Yu‐Feng Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Huang, Chun-Yung, et al.. (2024). Rice Husk Silica Liquid Enhances Autophagy and Reduces Overactive Immune Responses via TLR-7 Signaling in Lupus-Prone Models. International Journal of Molecular Sciences. 25(18). 10133–10133. 1 indexed citations
3.
Wei, Yu‐Feng, et al.. (2023). Influence of Rifamycin on Survival in Patients with Concomitant Lung Cancer and Pulmonary Tuberculosis. Biomedicines. 11(12). 3130–3130.
4.
Kuo, Chih‐Hsi S., Po‐Lan Su, Yu‐Feng Wei, et al.. (2023). T790M detection rate after first-line combination therapy with bevacizumab and EGFR-TKIs in advanced NSCLC (TERRA Study). PubMed Central. 3 indexed citations
5.
Chang, Cheng‐Yu, Chung‐Yu Chen, Shih‐Chieh Chang, et al.. (2023). Factors associated with outcomes of second-line treatment for EGFR-mutant non-small-cell lung cancer patients after progression on first- or second-generation EGFR-tyrosine kinase inhibitor treatment. Frontiers in Oncology. 13. 1104098–1104098. 1 indexed citations
6.
7.
Li, Dan, Ru‐Shi Liu, Xiuyi Wang, et al.. (2021). Abnormal ventral attention network homogeneity in patients with right temporal lobe epilepsy. SHILAP Revista de lepidopterología. 7 indexed citations
8.
Debele, Tilahun Ayane, Ping-Ching Wu, Yu‐Feng Wei, et al.. (2021). Transferrin Modified GSH Sensitive Hyaluronic Acid Derivative Micelle to Deliver HSP90 Inhibitors to Enhance the Therapeutic Efficacy of Brain Cancers. Cancers. 13(10). 2375–2375. 8 indexed citations
9.
Liao, Kuang‐Ming, et al.. (2021). Impact of Chronic Obstructive Pulmonary Disease on the Mortality of Patients with Small Cell Lung Cancer. SHILAP Revista de lepidopterología. 5 indexed citations
10.
Lin, Yen‐Ting, Chi‐Lu Chiang, Jen‐Yu Hung, et al.. (2021). Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non–small-cell lung cancer: a multicenter study using targeted next-generation sequencing. European Journal of Cancer. 156. 1–11. 25 indexed citations
11.
12.
Lin, Shu‐Wen, Chih‐Yuan Lee, Yu‐Feng Wei, et al.. (2020). CD4 response of QuantiFERON-TB Gold Plus for positive consistency of latent tuberculosis infection in patients on dialysis. Scientific Reports. 10(1). 21367–21367. 3 indexed citations
13.
Wei, Yu‐Feng, et al.. (2019). Intracranial Responses to Afatinib at Different Doses in Patients With EGFR-mutated Non–small-cell Lung Carcinoma and Brain Metastases. Clinical Lung Cancer. 20(3). e274–e283. 19 indexed citations
14.
Hung, Chih‐Hsing, Chin-Chou Wang, Jau‐Ling Suen, et al.. (2018). Altered pattern of monocyte differentiation and monocyte-derived TGF-β1 in severe asthma. Scientific Reports. 8(1). 919–919. 23 indexed citations
15.
Wei, Yu‐Feng, Ying‐Huang Tsai, Chin‐Chou Wang, & Ping‐Hung Kuo. (2017). Impact of overweight and obesity on acute exacerbations of COPD – subgroup analysis of the Taiwan Obstructive Lung Disease cohort. International Journal of COPD. Volume 12. 2723–2729. 34 indexed citations
16.
Hsu, Ren‐Jun, et al.. (2016). Scabies increased the risk and severity of COPD: a nationwide population-based study. International Journal of COPD. Volume 11. 2171–2178. 12 indexed citations
17.
Chang, Chih-Hao, Li‐Pang Chuang, Shih‐Wei Lin, et al.. (2016). Factors responsible for poor sleep quality in patients with chronic obstructive pulmonary disease. BMC Pulmonary Medicine. 16(1). 118–118. 45 indexed citations
18.
Xiong, Jiang, Yu‐Feng Wei, D. Chen, et al.. (2015). Potential Interactions Between Genetic Polymorphisms of the Transforming Growth Factor-β Pathway and Environmental Factors in Abdominal Aortic Aneurysms. European Journal of Vascular and Endovascular Surgery. 50(1). 71–77. 11 indexed citations
19.
Wei, Yu‐Feng, et al.. (2011). Tuberculosis manifesting as an invasive pulmonary mass and liver nodules mimicking malignancy with metastases. QJM. 105(2). 203–204. 2 indexed citations
20.
Wei, Yu‐Feng, Huey‐Dong Wu, Chi‐Yang Chang, et al.. (2009). The Impact of Various Anthropometric Measurements of Obesity on Pulmonary Function in Candidates for Surgery. Obesity Surgery. 20(5). 589–594. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Athena Gogali Breakdown of academic impact, for papers by Hideo Ichimura Breakdown of academic impact, for papers by Chin‐Hao Chang Breakdown of academic impact, for papers by Mehmet Sinan Dal Breakdown of academic impact, for papers by Choonghyun Ahn Breakdown of academic impact, for papers by Nathan Rubin Breakdown of academic impact, for papers by Kristen T. Leeman Breakdown of academic impact, for papers by Colin Robertson Breakdown of academic impact, for papers by Mohammad F. Madhoun Breakdown of academic impact, for papers by Ryo Suzuki
Rankless by CCL
2026